A new experimental painkiller has shown promise in dulling or eliminating pain without the addictive qualities exhibited by ...

Researchers from the University of Missouri School of Medicine have shed light on which populations are more likely to be ...

An experimental painkiller could be the key to solving the opioid epidemic - The drug could offer powerful pain relief ...

New Orleans biotech South Rampart Pharma advances non-opioid pain drug with $8M funding from Ochsner Ventures and Gulf South ...

Chronic pain affects more than 50 million Americans and remains one of the most difficult conditions to treat safely and effectively. While opioids have lo | Drug Discovery And Development ...

Long Island, once at the forefront of the opioid epidemic, has seen its overdose numbers consistently decline in recent years ...

The standard is associated with both an accelerated decline in opioid prescribing and aggressive dose tapering.

The number of Americans using illicit opioids, including fentanyl, is 20 times higher than previously estimated, according to ...

The two efforts were awarded $500,000 research grants each in collaboration with Novant Health, UNC Health and the University ...